Amneal files corrected bylaws as part of 8-K/A amendment to prior merger filing

Amneal Pharmaceuticals, Inc.

Amendment No.1 corrects Exhibit 3.2 (Amended and Restated Bylaws) from Nov 7, 2023 merger.
No other changes from original 8-K; all other exhibits remain unchanged.
Original 8-K reported merger agreements and related amendments to employment and governance documents.

item 9.01

Amneal Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-296632

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.